Results 91 to 100 of about 77,535 (306)

Considerations and Tips for Promoting Skin Barrier Maintenance and Quality of Life in Patients With Diabetes Mellitus: An Expert Consensus

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Skin changes such as xerosis and pruritus are common complications among diabetes patients and may lead to serious adverse events such as diabetic foot syndrome and amputations. Evidence suggests that daily application of optimal skincare, including gentle cleansers and moisturizers, may help improve skin barrier function, preventing ...
Robert S. Kirsner   +5 more
wiley   +1 more source

Hodgkin's Lymphomas: A Tumor Recognized by Its Microenvironment

open access: yesAdvances in Hematology, 2011
Thomas Hodgkin's and Samuel Wilks first recognized Hodgkin disease in the first half of the 19th century. Initially described as lymphogranulomatosis, it was later recognized to be a lymphoid neoplasm derived from B cells and was classified on the basis ...
S. Montes-Moreno
doaj   +1 more source

Depressed in vitro lymphocyte responses to PHA in patients with Hodgkin disease in continuous long remissions [PDF]

open access: bronze, 1977
DC Jr Case   +6 more
openalex   +1 more source

Hodgkin Lymphoma With Rapidly Destructive, Cavity-Forming Lung Disease [PDF]

open access: bronze, 2013
Takeshi Saraya   +11 more
openalex   +1 more source

Categorization of Reasons for Hospitalizations in Patients With Cutaneous T‐Cell Lymphoma

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Cutaneous T‐cell lymphomas (CTCL) can significantly impact patients' quality of life as well as impose a substantial healthcare burden due to their complex management and risk of hospitalization. Objectives This study aimed to identify factors associated with hospital admissions among patients with CTCL and to characterize the ...
Geetha Gowda   +6 more
wiley   +1 more source

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model [PDF]

open access: bronze, 2001
Craig H. Moskowitz   +18 more
openalex   +1 more source

Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease, survival, and toxicity [PDF]

open access: gold, 2023
William G. Breen   +15 more
openalex   +1 more source

Assessment of Treatment Response in Patients With Scleromyxedema by the Double Modified Rodnan Skin Score

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Scleromyxedema (SMX) is a cutaneous mucinosis characterised by an abnormal accumulation of mucin in the skin and limited treatment options. Assessment of therapy response during treatment is challenging. Objectives Patients with SMX receiving high‐dose intravenous IVIg therapy were included to assess validity of the double modified ...
Julia K. Winkler, Alexander H. Enk
wiley   +1 more source

IS HODGKIN’S DISEASE AN INFECTIOUS DISEASE? [PDF]

open access: yesIranian Journal of Public Health, 1979
The exact cause or causes of Hodgkin's disease have not yet been determined. The etiology of the disease suggests, but has not verified, a possible immunological and/or viral relationship.
N. Izadian
doaj  

Kaempferitrin's Dual Assault: Inducing Apoptosis and Ferroptosis in Diffuse Large B‐Cell Lymphoma via NF‐κB Inactivation

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Diffuse large B‐cell lymphoma (DLBCL) is the most common non‐Hodgkin lymphoma and is an aggressive and highly heterogeneous tumor. Kaempferitrin (KPF) is a natural flavonoid glycoside that exerts a protective role in multiple human tumors. However, the impact of KPF on DLBCL remains unclear.
Han‐Shuo Zhang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy